AXT Pty Ltd

The COVID-19 pandemic is crippling the world and its full effects will not be felt for many years to come. Researchers have scrambled to characterize the SARS-CoV2 virus so they can help develop a vaccine for this insidious disease.

The surface science capabilities at the Australian institute for Innovative Materials (AIIM) at the University of Wollongong (UoW) have recently been upgraded with the installation of a highly versatile Thermo Scientific NEXSA XPS (X-ray Photoelectron...

Bioprinting holds enormous promise in medicine in areas such as tissue engineering, regenerative medicine and drug discovery.

The Victorian Cancer Biobank (VCB) is a crucial part of the medical research landscape supporting researchers throughout Australia and around the world with the aim of delivering better clinical outcomes to people suffering with cancer.

AXT is excited to add the Vieworks range of bio-imaging systems to their preclinical imaging product portfolio. Their in-vivo imaging systems provide outstanding performance in bioluminescent and fluorescent imaging and represents excellent value.

Medical research is an important part of the Australian research landscape and one that AXT is committed to supporting.

With Australia having a vast wealth of mineral resources and mining being a key factor in the nations' economy, understanding mineral deposits is of key importance.

AXT has further consolidated its position as a diversified supplier of life science products with the addition of LabTIE International's innovative range of laboratory products and consumables.

AXT and Delmic are proud of a first in the world installation.

AXT are proud to announce that they have partnered with France-based Poietis to bring their next-generation bioprinting platforms to Australia.